Back to search

Article

Viral soluble decoy receptor as a novel treatment for IFN-I triggered diseases

2025-08-15

Abstract excerpt

Besides its antiviral action, type I interferon (IFN-I) plays a key role in triggering the inflammatory response and immunopathology in a group of autoinflammatory disorders known as interferonopathies. Current therapies for these diseases focus on blocking IFN-I signaling at different levels, but with incomplete success. Throughout evolution, to counteract the host immune response, poxviruses have developed decoy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
104a927f-200d-5837-9b9b-9b60966e38d2
DOI
10.1101/2025.08.12.669887
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Viral soluble decoy receptor as a novel treatment for IFN-I triggered diseasesDOI 10.1101/2025.08.12.669887
Select a neighboring publication to make it the new centre.